Company Description
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States.
The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices.
It also offers other healthcare products and services, including subscriptions and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform.
In addition, the company provides healthcare products and solution for dogs, cats, and other pets. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies.
The company was founded in 2011 and is headquartered in Santa Monica, California.
Country | United States |
Founded | 2011 |
IPO Date | Sep 23, 2020 |
Industry | Health Information Services |
Sector | Healthcare |
Employees | 738 |
CEO | Wendy Barnes |
Contact Details
Address: 2701 Olympic Boulevard Santa Monica, California 90404 United States | |
Phone | 855 268 2822 |
Website | goodrx.com |
Stock Details
Ticker Symbol | GDRX |
Exchange | NASDAQ |
Stock Type | Common Stock |
Share Class | Class A Shares |
Fiscal Year | January - December |
Reporting Currency | USD |
IPO Price | $33.00 |
CIK Code | 0001809519 |
CUSIP Number | 38246G108 |
ISIN Number | US38246G1085 |
Employer ID | 47-5104396 |
SIC Code | 7374 |
Key Executives
Name | Position |
---|---|
Wendy Barnes | President, Chief Executive Officer and Director |
Trevor Bezdek | Co-founder and Co-Chairman of the Board |
Douglas Joseph Hirsch | Co-founder and Director |
Romin Nabiey | Chief Accounting Officer |
Bansi Nagji | President of Healthcare |
Christopher A. McGinnis | Chief Financial Officer and Treasurer |
Nitin Shingate | Chief Technology Officer |
Aubrey Reynolds | Director of Investor Relations |
Gracye Cheng | Senior Vice President, General Counsel and Secretary |
Ryan Sullivan | Chief Marketing Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 23, 2025 | ARS | Filing |
Apr 23, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
Apr 23, 2025 | DEF 14A | Other definitive proxy statements |
Mar 21, 2025 | SCHEDULE 13D/A | Filing |
Mar 18, 2025 | SCHEDULE 13D/A | Filing |
Mar 18, 2025 | SCHEDULE 13D/A | Filing |
Mar 18, 2025 | SCHEDULE 13D/A | Filing |
Mar 17, 2025 | 8-K | Current Report |
Feb 27, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
Feb 27, 2025 | 10-K | Annual Report |